Mass Medical Angels is dedicated to providing funding and mentoring services the companies in the healthcare and life sciences sector.
Business Model:
Revenue: $0
Employees: 0-0
Address: -
City: Boston
State: MA
Zip: -
Country: US
Mass Medical Angels (MA2) was founded to answer the need for a dedicated life-science centric angel group in New England. The Boston area is a world-leading supercluster for medical innovation, but all early-stage companies in the field have tremendous difficulty with first round funding. Their goal is to provide money and mentoring to the life science community to achieve superior returns for their group, and more clinical innovation for the community.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
8/2011 | Lantos Technologies | Venture Round | 4.1M |
6/2012 | Diffinity Genomics | Series B | - |
3/2018 | Lantos Technologies | Venture Round | 0 |
4/2017 | Sentien Biotechnologies | Series A | 12M |
5/2021 | Astrocyte Pharmaceuticals | Series A | 0 |
9/2010 | Lantos Technologies | Venture Round | 1.6M |
6/2009 | lifeIMAGE | Series A | 2.7M |
2/2011 | Bliss Health | Seed Round | 500k |
2/2014 | Sialix Cancer Research | Series B | 1.2M |
12/2020 | Coviu | Venture Round | 0 |
4/2014 | InfoBionic | Series B | 0 |
5/2011 | MoMelan Technologies | Series A | - |
2/2012 | Avaxia Biologics | Series A | 0 |
2/2014 | Siamab Therapeutics | Series B | 0 |
9/2010 | Polytouch Medical | Seed Round | 830k |
10/2009 | Daktari Diagnostics | Series A | 2.8M |
6/2018 | Astrocyte Pharmaceuticals | Seed Round | 0 |
7/2013 | Siamab Therapeutics | Series B | 2.5M |
6/2013 | Avaxia Biologics | Series B | 0 |
12/2012 | Avaxia Biologics | Series B | 0 |
4/2014 | Sentieon | Series A | 0 |
12/2009 | lifeIMAGE | Series A | 2.2M |
12/2011 | lifeIMAGE | Series B | 8.1M |
8/2018 | Capillary Biomedical | Seed Round | 0 |
5/2021 | Astrocyte Pharmaceuticals | Series A | 0 |
12/2020 | Coviu | Venture Round | 0 |
8/2018 | Capillary Biomedical | Seed Round | 0 |
6/2018 | Astrocyte Pharmaceuticals | Seed Round | 0 |
3/2018 | Lantos Technologies | Venture Round | 0 |
4/2017 | Sentien Biotechnologies | Series A | 0 |
4/2014 | InfoBionic | Series B | 0 |
4/2014 | Sentieon | Series A | 0 |
2/2014 | Sialix Cancer Research | Series B | 0 |
2/2014 | Siamab Therapeutics | Series B | 0 |
Name | Price |
---|
Name | Size | Announced Date |
---|